Clinical Laboratory, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
Institute for Complex Molecular Systems and Department of Biomedical Engineering, Laboratory of Chemical Biology, Eindhoven University of Technology, Eindhoven, The Netherlands.
Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):807-813. doi: 10.1007/s10096-020-04076-3. Epub 2020 Oct 26.
The purpose of this study is to develop a one-step droplet digital RT-PCR (RT-ddPCR) multiplex assay that allows for sensitive quantification of SARS-CoV-2 RNA with respect to human-derived RNA and could be used for screening and monitoring of Covid-19 patients. A one-step RT-ddPCR multiplex assay was developed for simultaneous detection of SARS-CoV-2 E, RdRp and N viral RNA, and human Rpp30 DNA and GUSB mRNA, for internal nucleic acid (NA) extraction and RT-PCR control. Dilution series of viral RNA transcripts were prepared in water and total NA extract of Covid-19-negative patients. As reference assay, an E-GUSB duplex RT-PCR was used. GUSB mRNA detection was used to set validity criteria to assure viral RNA and RT-PCR assay quality and to enable quantification of SARS-CoV-2 RNA. In a background of at least 100 GUSB mRNA copies, 5 copies of viral RNA are reliably detectable and 10 copies viral RNA copies are reliably quantifiable. It was found that assay sensitivity of the RT-ddPCR was not affected by the total NA background while assay sensitivity of the gold standard RT-PCR assay is drastically decreased when SARS-CoV-2 copies were detected in a background of total NA extract compared with water. The present study describes a robust and sensitive one-step ddRT-PCR multiplex assay for reliable quantification of SARS-CoV-2 RNA. By determining the fractional abundance of viral RNA with respect to a human housekeeping gene, viral loads from different samples can be compared, what could be used to investigate the infectiveness and to monitor Covid-19 patients.
本研究旨在开发一种一步法数字 RT-PCR(RT-ddPCR)多重检测方法,该方法可以灵敏地定量 SARS-CoV-2 RNA 相对于人源 RNA 的含量,可用于新冠病毒患者的筛查和监测。建立了一种一步法 RT-ddPCR 多重检测方法,用于同时检测 SARS-CoV-2 的 E、RdRp 和 N 病毒 RNA,以及人源 Rpp30 DNA 和 GUSB mRNA,用于内部核酸(NA)提取和 RT-PCR 对照。在水中和新冠病毒阴性患者的总 NA 提取物中制备了病毒 RNA 转录本的稀释系列。作为参考检测方法,使用了 E-GUSB 双靶 RT-PCR。GUSB mRNA 的检测被用于设置有效性标准,以确保病毒 RNA 和 RT-PCR 检测的质量,并能够定量 SARS-CoV-2 RNA。在至少 100 个 GUSB mRNA 拷贝的背景下,可以可靠地检测到 5 个拷贝的病毒 RNA,并且可以可靠地定量到 10 个拷贝的病毒 RNA 拷贝。研究发现,与水中相比,当在总 NA 提取物的背景下检测 SARS-CoV-2 拷贝时,本 RT-ddPCR 检测方法的检测灵敏度不受总 NA 背景的影响,而金标准 RT-PCR 检测方法的检测灵敏度则明显降低。本研究描述了一种稳健而灵敏的一步法 ddRT-PCR 多重检测方法,可用于可靠地定量 SARS-CoV-2 RNA。通过确定病毒 RNA 相对于人类管家基因的分数丰度,可以比较来自不同样本的病毒载量,这可用于研究传染性并监测新冠病毒患者。